Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EXOSC9 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | CDA | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | AGPAT5 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | GOLGA2 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | CHAF1A | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | POLA1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | GRAMD3 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
mRNA | PCNA | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | MTA2 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | CTC1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |